Keywords
Polyvinylpyrrolidone, PVP, povidone, opioid substitution therapy, opioid substitution drugs, methadone, adverse effect, case report
Polyvinylpyrrolidone, PVP, povidone, opioid substitution therapy, opioid substitution drugs, methadone, adverse effect, case report
Based on the review reports from the reviewers, we have revised sections of the text and added a reference.
Key words: Case report removed. Foreign material and histiocytic storage added.
Result section:
Under the sub-heading “Biopsy findings”: We have added “in Congo red stain or any other stain.” to the last sentence.
Under the sub-heading “Further development”: We have added a sentence about thrombocytopenia and leukocytopenia.
Under the subheading “Autopsy findings”: We have added a sentence about the absence of symptoms of cardiac dysfunction. Sentences about findings in the pancreatic tissue altered for clarification. Sentence added about glomerular findings. Sentence added about signs of acute inflammation. For clarification, we have made a minor revision to the legend for Figure 4.
Discussion section:
In the second paragraph of the discussion: We have added a sentence about differentiating PVP deposits from deposits of crospovidone. New reference added: Ganesan S, Felo J, Saldana M, Kalasinsky VF, Lewin-Smith MR, Tomashefski JF, Jr. (2003) Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users. Mod Pathol 16(4):286-92. https://doi.org/10.1097/01.mp.0000062653.65441.da
See the authors' detailed response to the review by Maike Büttner-Herold
See the authors' detailed response to the review by Robert Barnes Colvin
Injection of oral opioid substitution drugs (OSD) is a concern in the treatment of opioid dependency. An Australian study found that 7–13% of clients in opioid substitution therapy (OST) injected their medication weekly or more often.1 The OSDs may also be sold on the illegal drug market, and 26.6% of out-of-treatment intravenous drug users in a Norwegian study reported having injected methadone during the past 4 weeks.2 Injection of oral or sublingual drug formulations may lead to vascular and soft tissue damage with a range of secondary complications.3
Several OSDs contain the excipient polyvinylpyrrolidone (PVP),4 a water-soluble polymer with a wide variety of applications in the pharmaceutical industry.5 When orally ingested, PVP is not absorbed, and causes no harm.6,7 When injected, PVP is not metabolized, and the only way of excretion is via glomerular filtration.6 While low molecular weight (MW) PVP is freely filtered by the glomerulus, PVP with moderate or high MW will be partly or completely retained in the body.6,8 In the middle part of the last century, PVP was utilized as a plasma expander9 and as a retarding agent in hormone preparations for injection.10 Reports from this time described storage in multiple tissues following repeated parenteral administrations of PVP-containing preparations.9–11
We report a case of extensive PVP-deposition disease with a fatal outcome following long-term injection of PVP-containing OSDs.
A male, 30-year-old drug addicted patient in OST was admitted to the local hospital. He was hepatitis C positive and had a history of hospitalisations for skin infection. At admittance, he was in a poor general condition with nausea, vomiting, abdominal pain and muscle aches. Physical examination revealed a diffusely tender abdomen and poor dental status. Laboratory investigations disclosed non-specific inflammatory signs with an increased erythrocyte sedimentation rate (83 mm/h) and C-reactive protein (CRP, 90 mg/L), severe normocytic anaemia with a haemoglobin of 7.8 g/dL and renal insufficiency (serum creatinine 133 μmol/L, estimated glomerular filtration rate 60.1 mL/min/1.73m2) with microalbuminuria. Blood cultures were negative. Radiological examinations of the thorax and abdomen showed splenomegaly and a pancreatic cyst, but otherwise no radiologic signs of infection, malignancy or kidney pathology. His CRP and serum creatinine levels fell spontaneously, and he left the hospital against the doctor’s advice after four days.
Two months later, the patient fractured his right clavicle. After a two-week delay, he was admitted to hospital with a fever and a swollen and erythematous clavicular region. His general condition and nutritional status had worsened, nausea and vomiting persisted and anaemia and renal insufficiency had relapsed. Blood cultures were positive for Staphylococcus aureus, and antibiotic treatment against suspected osteomyelitis was initiated. Magnetic resonance imaging (MRI) of the clavicular region and the upper arm showed mottled signal changes with a high signal intensity in the lateral clavicle, the humeral bone and the acromion (Figure 1a). The diagnoses considered at this time were osteomyelitis or malignancy. Biopsies from the fractured bone, bone marrow and gastric mucosa were performed in the work-up of this complex symptomatology.
(a) MRI (T2-blade-sag-FS) of the right humerus showing mottled signal changes. (b) Clavicular bone (H&E): The marrow space is infiltrated by histiocytes with bluish transparent bubbles. (c) Bone marrow (H&E): Massive infiltration of histiocytes and scarce remaining hematopoietic tissue. (d) Gastric mucosa (H&E): Infiltration of vacuolated histiocytes in an extended lamina propria. All scale-bars 50 μm.
The biopsies all showed similar infiltrates of histiocytes with a cytoplasm extended by vacuoles of different sizes (Figure 1b–d) and eccentrically located nuclei.
Biopsies from the fractured bone revealed reactive changes with ongoing fibrosis. The fibrotic tissue contained the multivacuolated histiocytes as singular cells, small groups or sheets of cells (Figure 1b). The bone marrow biopsy showed massive histiocytic infiltrates (Figure 1c). There was reduced fat cell content, and there was almost no visible hematopoietic tissue. The gastric biopsy showed antrum mucosa with elongated gastric pits and aggregates of multivacuolated histiocytes in both the superficial and deep lamina propria (Figure 1d). A gastric biopsy taken two years previously was re-examined. It showed the same histiocytic infiltrates; however, the findings did not lead to the correct diagnosis at the time.
In the hematoxylin and eosin (H&E) stain, the vacuoles had distinct membranes and a bluish, transparent looking content. Vacuole content did not stain in the periodic acid Schiff (PAS), Prussian blue or Alcian blue stain. The cells were positive for CD68/PGM1 confirming the histiocytic nature (Figure 2a). The vacuoles stained red in Congo red stain and black in the periodic acid methenamine silver (PASM) stain (Figure 2b and c). The vacuoles did not show birefringence in Congo red stain or other stains.
The microscopic appearance of the vacuolated histiocytes and the histochemical staining properties were consistent with PVP deposition.12,13 At that time, several of the OSDs marketed in Norway contained PVP.4 Our patient had injected both buprenorphine tablets and methadone syrup regularly over several years. The buprenorphine tablets contained PVP K30 (MW 44–54 kDa). The specific methadone syrup he had been injecting contained large amounts of PVP K90 (MW 1 000–1 500 kDa).14 While much of the PVP K30 is expected to be excreted within weeks, PVP K90 will not be excreted and consequently accumulates in the body.6 It is therefore plausible that injections of the PVP K90-containing methadone syrup were the cause of the PVP-deposition disease in this patient. Based on the history of this patient and other similar cases,15,16 the European Medicines Agency suspended this methadone syrup in 2014.14
After the diagnosis was made, the patient’s health gradually declined, in part due to his poor self-care and underlying chronic drug addiction. There is no specific treatment for PVP deposition disease. His persistent anaemia was treated with regular blood transfusions and erythropoietin-stimulating agents with limited effect. He had short episodes of mild thrombocytopenia and leukocytopenia, and, in general, his leukocyte response to infection was weak. The kidney failure was managed by supportive treatment, and serum creatinine levels fluctuated between 150 and 450 μmol/L.
Within the first year of the diagnosis, the patient suffered a left sided pathological femoral neck fracture with impaired fracture healing, complicated by chronic osteomyelitis. In the right hip, he developed severe bone destruction of the acetabulum with dislocation of the femoral head and a subsequent femoral neck fracture (Figure 3a). MRI scans of both hips and the pelvis (not shown) revealed the same changes as those detected in the shoulder region. Biopsies from the greater trochanter region showed extensive histiocytic infiltrates (Figure 3b). Surgical treatments were unsuccessful. Henceforth his mobility deteriorated to such a degree that he needed a wheelchair and required daily activity support and care in a palliative care centre. Furthermore, he developed endocrine pancreas insufficiency with insulin-dependent diabetes mellitus. He had a gradual weight loss of 22 kg during four years despite adequate food intake. Malabsorption due to exocrine pancreas insufficiency was suspected, but supplementation of pancreas enzymes had little effect on the weight loss.
(a) Pelvic radiograph. Left hip: The hip prosthesis has been removed due to loosening and replaced by a Girdlestone hip. Right hip: Extensive lytic and sclerotic changes in the proximal femur and acetabulum leading to medial dislocation of the femoral head. (b) Biopsy from the right greater trochanter (H&E): The marrow space is filled with histiocytes with the bluish vacuoles characteristic of PVP-deposition. The bone trabecula has empty lacunar spaces and contains a bluish material. Scale bar 50 μm.
Five years after the diagnosis of PVP deposition disease, the patient died, impaired by multi-organ failure and advanced cachexia with a body mass index below 15 kg/m2.
The autopsy concluded that the immediate cause of death was multi organ failure due to PVP deposition disease, which in turn was a consequence of the patient’s illicit substance abuse. The following organs and tissues were sampled during the autopsy: the pericardium and myocardium, the pleura and lungs, kidneys, liver, pancreas, gastric mucosa, adrenal glands, peritoneum and abdominal adipose tissue, the spleen, lymph nodes, and femoral bone and bone marrow. Microscopically, we observed PVP-deposition in all sampled organs and tissues (Figure 4). The PVP-containing histiocytes were partly scattered in the interstitium, e.g. in the myocardium (Figure 4a), and partly organised like larger, nodular lesions, e.g. in the pleura (Figure 4b). Peri- and intra-neural distribution was seen in several organs including the heart. However, there were no clinical, echocardiographic or electocardiographic evidence of impaired cardiac output or arrhythmias prior to his death. Autopsy findings corresponded well with the clinically observed pancreas and kidney insufficiency. There was little preserved exocrine and endocrine pancreas parenchyma. The pancreatic tissue was dominated by dense fibrosis interspersed by heavy infiltrations of histiocytes (Figure 4c). The kidney showed moderate to severe interstitial fibrosis and tubular atrophy, and only minor glomerular changes. There were infiltrates of PVP-containing histiocytes in the interstitium, mostly in atrophic areas (Figure 4d). In glomeruli, we observed a slightly increased number of histiocytes and occasional PVP-containing vacuoles. There were no amyloid depositions or signs of other renal diseases. The autopsy revealed no evidence of infection besides minor foci of acute inflammation in the pancreas.
Infiltrates of histiocytes with the bluish vacuoles characteristic of PVP in all organs. (a) Myocardium: Interstitial fibrosis and histiocytic infiltrates. Scale bar 50 μm. (b) Pleura: Nodular lesion composed of fibrotic tissue and histiocytes. We found similar lesions in the pericardium and peritoneum. These were macroscopically visible. Scale bar 200 μm. (c) Pancreas: Pronounced fibrosis with histiocytic infiltrates. Poorly preserved ductal structures. Scale bar 50 μm. (d) Kidney: Cortical tissue showing interstitial fibrosis, tubular atrophy, and an infiltrate of histiocytes in the extended interstitium. Scale bar 50 μm.
We present the case of a drug-addicted patient with widespread PVP-deposition disease. We describe the patient’s clinical course from the first diagnosis of PVP-deposition to his death five years later and present biopsy and autopsy findings. The PVP deposition disease in this patient was likely caused by repeated intravenous injections of a methadone syrup containing high MW PVP.
The characteristic appearance and staining properties of PVP in tissue samples are well known.17 Positivity for Congo red and PASM and negativity for PAS distinguishes PVP deposits from those seen in hereditary storage diseases. The histiocytic nature of the cells and the PAS negativity rule out metastatic signet ring cell carcinoma as a differential diagnosis.17 PVPs light blue color in H&E and the typical localization of the deposits differentiates it from the non-water soluble variant of PVP, crospovidone.18 Furthermore, PVP is not birefringent, unlike most other foreign materials commonly observed in tissue samples from injecting drug users.19 Hence, making the diagnosis of PVP deposition is straightforward if this option is considered.
Whether PVP deposition causes disease was controversial for a long time. The first reports of PVP- deposition described storage in the tissue that persisted years after the administration of PVP, but disputed whether the storage was harmful to the functioning of the target organs.20 Later reports described clinically relevant adverse effects. Those most frequently reported were cytopenias, bone destruction, polyneuropathy and granulomatous lesions of the skin.17,21–24 PVP deposition in internal organs such as the liver, kidneys, pancreas and the gastrointestinal tract has also been described, but the adverse effect of the deposition in these organs is less well known.25,26
Our patient experienced a complex clinical syndrome and rapidly deteriorating health. The reason for his health decline was multifactorial, and his continued drug addiction likely aggravated the clinical course. Many of the clinical conditions associated with the fatal outcome correspond to findings in biopsies and the autopsy showing extensive PVP deposition. We believe that the extensive PVP deposition contributed to his health decline through several mechanisms. The widespread PVP deposition in bone and bone marrow was likely the main reason for the patient’s anaemia, pathological fractures and impaired fracture healing, fitting well with previous reports.21,23,24 The impaired mobility and chronic osteomyelitis that resulted from these fractures gravely affected his health and quality of life. Furthermore, progressive cachexia was an important part of his health decline. The reason for the weight loss was not established during his lifetime, but his continued drug use likely contributed. Other possible contributing factors were pancreas insufficiency, progressive kidney failure, malabsorption, chronic infections and continued problems with vomiting, all likely related to the extensive PVP deposition. In summary, the PVP deposition probably played a major role in causing the patients’ multiple organ dysfunction ultimately leading to the fatal outcome.
Injection of oral OSDs is common among injecting drug users and has long been a concern in the treatment of opioid addiction.2 As an attempt to prevent injections, the previously mentioned methadone syrup was made highly viscous.14 However, the increased viscosity did not prevent such unintended use. As a consequence, the choice of high MW PVP as thickener caused further severe adverse effects from injection.
This case revealed an unanticipated explanation for anaemia and pathological fractures in a drug-addicted patient. The correct identification of the observed foreign material as PVP revealed that injection of a certain methadone syrup containing PVP probably caused the patient’s deposition disease. Based on the clinical history, biopsy and autopsy findings, we conclude that the widespread PVP deposition likely contributed to the patient’s severe morbidity and death.
PVP: Polyvinylpyrrolidone
OSD: Opioid substitution drug
OST: Opioid substitution therapy
H&E: Hematoxylin and eosin stain
PASM: Periodic acid methenamine silver stain
PAS: Periodic acid Schiff stain
CRP: C-reactive protein
MRI: Magnetic resonance imaging
MW: Molecular weight
All data underlying the results are available as part of the article and no additional source data are required.
Zenodo: CARE checklist for “Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: report of a case with a fatal outcome”. https://doi.org/10.5281/zenodo.4667989.27
Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Universal).
Written informed consent for publication of the patient’s clinical details and clinical images was obtained from the patient prior to his death and from the closest relative.
Ida Viken Stalund was funded by The Western Norway Health Authority [grant number 912001].
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
We appreciate the contributions of the patient and his family in allowing us to discuss his care and findings. We thank Ingrid Vallevik and Stine Kristoffersen for performing the autopsy and Anna Emilia Kozak for valuable comments on the radiologic images.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: Maike Büttner-Herold is involved in an European initiative working on a harmonized Kidney biopsy coding (KBC) system, which is coordinated by S. Leh. It is a project in which a large number of European Nephropathologists are involved discussing in meetings of how to best construct a coding system. From time to time we also have Zoom-meetings or email correspondence. This, however, has nothing to do with the case report submitted.
Reviewer Expertise: Nephropathology, GvHD, immunology
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Yes
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
References
1. Ganesan S, Felo J, Saldana M, Kalasinsky VF, et al.: Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users.Mod Pathol. 2003; 16 (4): 286-92 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?
Partly
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?
Yes
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
Competing Interests: Maike Büttner-Herold is involved in an European initiative working on a harmonized Kidney biopsy coding (KBC) system, which is coordinated by S. Leh. It is a project in which a large number of European Nephropathologists are involved discussing in meetings of how to best construct a coding system. From time to time we also have Zoom-meetings or email correspondence. This, however, has nothing to do with the case report submitted.
Reviewer Expertise: Nephropathology, GvHD, immunology
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 2 (revision) 07 Jul 21 |
read | |
Version 1 19 Apr 21 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)